Baseline CD4 + T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients
Year: 2010
Type: article
Source: Antiviral Therapy
DOI: 10.3851/imp1759
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Pfizer
OpenAlex ID: W1995745448
